Deczuba 50mg Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Decitabine (50mg)
Overview Deczuba 50mg Injection
In acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), Deczuba 50mg Injection serves as a crucial treatment. Its application may extend to other conditions as directed by a physician. Often administered intravenously as part of combination chemotherapy, the dosage and frequency are determined by your doctor based on your specific condition and may vary. Strict adherence to the prescribed regimen is vital, as improper use can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent, discontinuation should only occur under medical guidance. Common side effects include nausea, vomiting, diarrhea, headache, fever, and pneumonia. A reduction in blood cell counts, potentially increasing infection risk, is a possible consequence. Regular blood tests, monitoring blood cell levels, heart function, liver health, and uric acid are essential. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, particularly anti-infectives, to your doctor. Numerous drug interactions are possible; complete medication disclosure is critical. Use during pregnancy or breastfeeding is contraindicated, and reliable contraception is strongly advised for both partners throughout treatment.
Primary Ingredients of Deczuba 50mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Deczuba 50mg Injection
Bone marrow failure disorder; a type of leukemia.
Major Benefits of Deczuba 50mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Deczuba 50mg Injection:
- Nausea
- Vomiting
- Headache
- Fever
- Lung infection
- Decreased white blood cell count (neutrophils)
- Nosebleeds
- Anemia (low number of red blood cells)
- Low blood platelets
- Diarrhea
- Pneumonia
How to use Deczuba 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Deczuba 50mg Injection works:
Deczuba 50mg Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of their fundamental components. This action inhibits the growth and replication of cancerous cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Deczuba 50mg Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Deczuba 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Deczuba 50mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Deczuba 50mg Injection may induce adverse reactions impacting driving capabilities. Fatigue or weakness following Deczuba 50mg Injection administration can impair driving ability.
KidneyCAUTION
Exercise caution when administering Deczuba 50mg Injection to individuals with impaired renal function. Dosage modification of Deczuba 50mg Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Deczuba 50mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Deczuba 50mg Injection :
NA
Facts to Know About Deczuba 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Azacitidine Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Metabolic inhibitors |
3,018 People bought this recently